Recent studies indicate that using S-adenosylmethionine (SAMe) supplements could be helpful in managing depression. Meta-analysis of studies suggest S-adenosylmethionine may provide relief similar to conventional antidepressants. With depression affecting millions worldwide, SAM-e’s ability to regulate neurotransmitters offers a new avenue for exploration. Gnosis by Lesaffre, the maker of the SAMe ingredient Adonat, emphasizes the importance of considering alternative treatments for depression management. As research continues, SAMe supplements could emerge as a valuable additional therapy option, improving outcomes for those dealing with depression.
Dark Chocolate: A Potential Ally Against Type 2 Diabetes
December 7, 2024
